Advertisement
Ph+CML is a cancer that affects the blood and bone marrow; approximately5,000 new cases are expected to be diagnosed this year. Until a few yearsago, a diagnosis of Ph+CML could mean a patient had only a few years ormonths left to live. Because of new treatments, it is now considered aserious, but manageable cancer for many.
Advertisement
Kareem is being treated with a medicine that specifically targets theabnormal protein, known as Bcr-Abl, which causes this leukemia. Today, Kareemcontinues to live a very full life and is feeling good about the future. Now,he is partnering with Novartis Oncology and has a message for fellow patientswith Ph+CML- work closely with your doctors and take all the necessary stepsto actively manage your disease for the best possible outcomes.
For more information, Kareem is encouraging fellow patients with Ph+CMLand their loved ones to visit www.CMLAlliance.com and www.CMLEarth.com. CMLAlliance offers helpful disease education, information about how treatmentswork to fight this cancer, the testing that is done to monitor treatmentresponse, and information on reimbursement support. CML Earth is a uniqueinteractive social networking website that allows Ph+CML patients to connectwith one another across the globe.
NEWS: Kareem Abdul-Jabbar Breaks Silence on Being Diagnosed with RareBlood Cancer
FORMAT: B-roll and Soundbites
ADDITIONAL RESOURCES: Video, contact information and more available at:http://multivu.prnewswire.com/broadcast/41103/consumer.html
VIDEO PROVIDED BY: Novartis
Contact: FOR MORE INFORMATION, PLEASE CALL: MultiVu Media Relations,1-800-653-5313 EXT. 3SATELLITE FEEDS: Tuesday, November 10th, 2009 Tuesday, November 10th, 2009 10:15 AM - 10:30 AM ET 1:15 PM - 1:30 PM ET Galaxy 19 AMC 3 C-Band C-Band Transponder 20 Transponder 3 Downlink Freq. 4100 Horizontal Downlink Freq. 3760 Horizontal
SOURCE Novartis
